Literature DB >> 32221037

A Critical Role of Formyl Peptide Receptors in Host Defense against Escherichia coli.

Meihua Zhang1,2, Ji-Liang Gao3, Keqiang Chen2, Teizo Yoshimura4, Weiwei Liang2,5, Wanghua Gong6, Xiaoqing Li2, Jiaqiang Huang2, David H McDermott3, Philip M Murphy3, Xietong Wang7, Ji Ming Wang8.   

Abstract

Formyl peptide receptors (FPRs, mouse Fprs) belong to the G protein-coupled receptor superfamily and mediate phagocyte migration in response to bacteria- and host-derived chemoattractants; however, knowledge about their in vivo roles in bacterial pathogenesis is limited. In this study, we investigated the role of Fpr1 and Fpr2 in host defense against Escherichia coli infection. In vitro, we found that supernatants from E. coli cultures induced chemotaxis of wild-type (WT) mouse bone marrow-derived neutrophils and that the activity was significantly reduced in cells genetically deficient in either Fpr1 or Fpr2 and was almost absent in cells lacking both receptors. Consistent with this, E. coli supernatants induced chemotaxis and MAPK phosphorylation in HEK293 cells expressing either recombinant Fpr1 or Fpr2 but not untransfected parental cells. WT bone marrow -derived neutrophils could actively phagocytose and kill E. coli, whereas both activities were diminished in cells lacking Fpr1 or Fpr2; again, an additive effect was observed in cells lacking both receptors. In vivo, Fpr1 and Fpr2 deficiency resulted in reduced recruitment of neutrophils in the liver and peritoneal cavity of mice infected with inactivated E. coli Moreover, Fpr1-/- and Fpr2-/- mice had significantly increased mortality compared with WT mice after i.p. challenge with a virulent E. coli clinical isolate. These results indicate a critical role of Fprs in host defense against E. coli infection.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32221037     DOI: 10.4049/jimmunol.1900430

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Lipopeptide Pepducins as Therapeutic Agents.

Authors:  Emily Michael; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2022

2.  A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn's Disease.

Authors:  Kai Nie; Chao Zhang; Minzi Deng; Weiwei Luo; Kejia Ma; Jiahao Xu; Xing Wu; Yuanyuan Yang; Xiaoyan Wang
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

3.  The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer.

Authors:  Cuimeng Tian; Keqiang Chen; Wanghua Gong; Teizo Yoshimura; Jiaqiang Huang; Ji Ming Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.

Authors:  Adriana Petrazzuolo; Julie Le Naour; Erika Vacchelli; Pascale Gaussem; Syrine Ellouze; Georges Jourdi; Eric Solary; Michaela Fontenay; David M Smadja; Guido Kroemer
Journal:  Oncoimmunology       Date:  2020-12-08       Impact factor: 8.110

5.  Fpr2/CXCL1/2 Controls Rapid Neutrophil Infiltration to Inhibit Streptococcus agalactiae Infection.

Authors:  Zeyu Sun; Wenhua Huang; Yuling Zheng; Peng Liu; Wenbo Yang; Zinan Guo; Decong Kong; Qingyu Lv; Xinyu Zhou; Zongmin Du; Hua Jiang; Yongqiang Jiang
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

Review 6.  Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.

Authors:  Cheng Xue Qin; Lucy V Norling; Elizabeth A Vecchio; Eoin P Brennan; Lauren T May; Denise Wootten; Catherine Godson; Mauro Perretti; Rebecca H Ritchie
Journal:  Br J Pharmacol       Date:  2022-07-29       Impact factor: 9.473

7.  The ambiguous role of FPR1 in immunity and inflammation.

Authors:  Erika Vacchelli; Julie Le Naour; Guido Kroemer
Journal:  Oncoimmunology       Date:  2020-04-30       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.